The most common side effect in clinical trials was headache (in about 10% of people who take it). Less common side effects (between 1 and 10% of people) included unspecific symptoms such as dizziness, fatigue, and nausea, but also depression. Possible rare side effects could not be assessed because of the low number of subjects in the clinical trials in which adverse effects were measured.
Migalastat
Cobicistat
Lazaretto
Miglustat
Truenat
Epiestriol
Lifitegrast
Ketotifen